Revolutionizing Healthcare: The Booming Global Market for Cell and Gene Therapy Logistics
According to Renub Research Latest Report healthcare landscape is shifting from generalized treatment to personalized medicine, and the cell and...
cell
Exosome Cell and Gene Therapy Market 2026 Drives by Rising
Ottawa, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The exosome cell and gene therapy market is rising due to the growing demand...
World-first gene-editing treatment for blood disorders including sickle cell disease approved for use in the NHS
World-first gene-editing treatment for blood disorders including sickle cell disease approved for use in the NHS ...
Capricor’s DMD Cell Therapy Faces FDA Setback
The developer of a new cell therapy for Duchenne muscular dystrophy (DMD) says it will continue to push for FDA...
Cell and gene therapy market set to grow at 44% CAGR through 2030, reveals GlobalData – Healthcare News
The global cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth rate of...
How subpar treatment options allow sickle cell disease to persist | Explained
When five-year-old Suraj was debilitated with a persistent fever, his family took him to the district hospital in Nuapada in...
Six steps healthcare leaders should consider before launching a cell and gene therapy program
Emerging novel cell and gene therapies allow for the possibility of untethering patients from a lifetime of burdensome, costly chronic...
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities
Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma:...
World’s first CRISPR-based gene therapy approved for sickle cell anaemia
Casgevy has been approved for treating sickle cell disease and transfusion-dependent beta thalassemia patients aged 12 and older in the...
